In summary, we propose that GHSROS is an oncogene that regulates cancer hallmarks and the expression of a number of genes, including the tumor suppressor PPP2R2C – the loss of which is an emerging alternative driver of prostate cancer. The gene discussed is PPP2R2C; the disease is prostate carcinoma.